PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025
PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025 GlobeNewswire May 16, 2025 TORONTO, May 16, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (“PharmaTher” or the “Company”), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today announced the U.S. Food and Drug […]